Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
Clinical trial NCT00848783 · TERMINATED
Trial details
- NCT number
- NCT00848783
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-08-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.